Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.19 USD
−2.18 M USD
1.76 M USD
11.34 M
About TherapeuticsMD, Inc.
Sector
Industry
CEO
Marlan D. Walker
Website
Headquarters
Boca Raton
Founded
1907
FIGI
BBG000LKB954
TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
John B. says 90% chance for a brake outI'm looking at TXMD again. Still bullish.
Only TA, no fundamentals this time:
The Bollinger band is an interesting tool that tells us now -as price is at the lower band (oversold) and in a situation when the band is very contracted (squeezed)- that likely a brake out will follow.
Add a positive di
$TXMD - Giant Inverted Cup and Handle on Weekly ChartA giant Inverted Cup and Handle can be observed for TXMD on weekly chart.
Starting around in Q3 2011, until Q3 2021, that's a giant most pattern I've ever observed! And unfortunately it's bearish!
Anyway, all the stakes I have in this company are from the profits that I earned from the same stock!
Best investment advice: I tell you before, not after.TXMD:
If you think mid term (swing trades) or if you are looking for a long term investment, in both cases this is still and again a good choice.
Just look at this weekly chart, this is about 10 years in front of us. Right now TXMD is way undervalued! Very cheap, on sale, seriously. Analysts target
TXMD BUY/LONG NOW READY! 1.85 to 3.50 by End 2021 - Early 2022!TICKER CODE: TXMD
Company Name: THERAPEUTICSMD, INC
US Stocks Health Technology Pharmaceuticals: Generic
Position Proposed: BUY
BUY ENTRY: NOW READY (1.25)
1st Partial Take Profit: 1.85 (Aug-Sept 2021)
2nd Partial Take Profit: 3.50 (End 2021-Early 2022)
3rd Partial Take Profit: 3.95 (End 2021-Ear
TXMDTherapeuticsMD Inc (NASDAQ:TXMD) finally broke out of its downtrend line yesterday on decent volume. If this chart does what is supposed to do, it will be going higher in the days to come. Technically, the stock is in a short-term Bull Market with share price above 9 and 13daily EMA. Let's see if ne
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of TXMD is 1.15 USD — it has increased by 0.88% in the past 24 hours. Watch TherapeuticsMD, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TherapeuticsMD, Inc. stocks are traded under the ticker TXMD.
TXMD stock has risen by 12.75% compared to the previous week, the month change is a 25.00% rise, over the last year TherapeuticsMD, Inc. has showed a −38.83% decrease.
TXMD reached its all-time high on Feb 2, 2010 with the price of 8,000.00 USD, and its all-time low was 0.70 USD and was reached on Dec 31, 2024. View more price dynamics on TXMD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TXMD stock is 9.25% volatile and has beta coefficient of 1.20. Track TherapeuticsMD, Inc. stock price on the chart and check out the list of the most volatile stocks — is TherapeuticsMD, Inc. there?
Today TherapeuticsMD, Inc. has the market capitalization of 13.31 M, it has increased by 2.04% over the last week.
Yes, you can track TherapeuticsMD, Inc. financials in yearly and quarterly reports right on TradingView.
TherapeuticsMD, Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
TXMD net income for the last quarter is 252.00 K USD, while the quarter before that showed −609.00 K USD of net income which accounts for 141.38% change. Track more TherapeuticsMD, Inc. financial stats to get the full picture.
No, TXMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 26, 2025, the company has 1 employees. See our rating of the largest employees — is TherapeuticsMD, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TherapeuticsMD, Inc. EBITDA is −2.98 M USD, and current EBITDA margin is −169.39%. See more stats in TherapeuticsMD, Inc. financial statements.
Like other stocks, TXMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TherapeuticsMD, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TherapeuticsMD, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TherapeuticsMD, Inc. stock shows the sell signal. See more of TherapeuticsMD, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.